Greenberg Traurig’s Tel Aviv office is collaborating with partners BNY Mellon and H.C. Wainwright & Co. LLC to host a morning roundtable focused on capital markets options for the life sciences industry.
The event will take place February 27th, 9:00 at Greenberg Traurig’s Tel Aviv office located in the Azrieli Round Tower (30th Floor).
Topics to be discussed include:
- Preparing for going public
- Various ways to go public and determining the appropriate route: reverse merger, full IPO, ADR vs. ordinary shares, registered direct offering, PIPE transactions, at-the-market offering
- Post IPO alternatives
- Relevant legal and business issues for companies going public
- Deciding upon and working with investment bankers
Leading the discussion:
Bob Grossman
Chair, Israel Practice;
Corporate, Securities and M&A Shareholder – Greenberg Traurig
Benjamin Brisedou
Vice President – BNY Mellon
Oded Spindel
Vice President – H.C. Wainwright & Co. LLC
Please click here to register
